Bariatric surgery and diabetes remission: how far have we progressed?

References

• Lima-Costa MF, Peixoto SV, Firmo JO, Uchoa E. Validity of self-reported diabetes and its determinants: evidences from the Bambui study. Rev Saude Publica 2007;41:947-53
   PubMedGoogle Scholar
• Holst JJ. Enteroendocrine secretion of gut hormones in diabetes, obesity and after bariatric surgery. Curr Opin Pharmacol 2013;13:983-8
   PubMed Web of Science ®Google Scholar
• Osborn O, Olefsky JM. The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med 2012;18:363-74
   PubMed Web of Science ®Google Scholar
• Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010;87:4-14
   PubMed Web of Science ®Google Scholar
• Padwal RS, Pajewski NM, Allison DB, Sharma AM. Using the Edmonton obesity staging system to predict mortality in a population representative cohort of people with overweight and obesity. CMAJ. 2011;183:E1059-66
   Google Scholar
• Wing RR, Bolin P, Brancati FL, et al. Look AHEAD Research Group. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med 2013;369:145-54
   PubMed Web of Science ®Google Scholar
• Consensus Development Conference Panel. Gastrointestinal Surgery for Severe Obesity. Ann Intern Med 1991;115(12):956-61
   PubMed Web of Science ®Google Scholar
• Thomas GN, Schooling CM, McGhee SM, et al. Hong Kong Cardiovascular Risk Factor Prevalence Study Steering Committee. Metabolic syndrome increases all-cause and vascular mortality: the Hong Kong Cardiovascular Risk Factor Study. Clin Endocrinol (Oxf) 2007;66(5):666-71
   PubMed Web of Science ®Google Scholar
• NICE. Obesity: guidance on the prevention, identification, assessment and management of overweight and obesity in adults and children. National Institute for Health and Clinical Excellence; London: 2006
   Google Scholar
• Kasama K, Mui W, Lee WJ, et al. IFSO-APC consensus statements 2011. Obes Surg 2012;22(5):677-84
   PubMed Web of Science ®Google Scholar
• Dixon JB, Zimmet P, Alberti KG, Rubino F; International Diabetes Federation Task force on Epidemiology and Prevention. Bariatric surgery: an IDF statement for obese Type 2 diabetes. Diabet Med 2011;28(6):628-42
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Standards of medical care in diabetes 2013 (position statement). Diabetes Care 2013;36(Suppl1):S11-66
   PubMedGoogle Scholar
• Schauer PR, Burguera B, Ikramuddin S, et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 2003;238:467-84
   PubMed Web of Science ®Google Scholar
• Sjostrom L, Narbro K, Sjostrom CD, et al. Swedish Obese Subjects Study. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007;357:741-52
   PubMed Web of Science ®Google Scholar
• Sjostrom L, Peltonen M, Jacobson P, et al. Bariatric surgery and long-term cardiovascular events. JAMA 2012;307:56-65
   PubMed Web of Science ®Google Scholar
• Sjostrom L, Gummesson A, Sjostrom CD, et al. Swedish Obese Subjects Study. Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial. Lancet Oncol 2009;10:653-62
   PubMed Web of Science ®Google Scholar
• Paik KY, Kim W, Song KH, et al. The preliminary clinical experience with laparoscopic duodenojejunal by pass for treatment of type 2 diabetes mellitus in non-morbidly obese patients: the 1-year result in a single institute. Surg Endosc 2012;26(11):3287-92
   PubMed Web of Science ®Google Scholar
• Kashyap SR, Gatmaitan P, Brethauer S, Schauer P. Bariatric surgery for type 2 diabetes: weighing the impact for obese patients. Cleve Clin J Med 2010;77:468-76
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Standards of medical care in diabetes—2009. Diabetes Care 2009;32:13-61
   PubMed Web of Science ®Google Scholar
• Kumar Kota S, Ugale S, Gupta N, et al. Remission of Type 2 Diabetes Mellitus by Ileal Interposition with Sleeve gastrectomy. Int J Endcrinol Metab 2011;9(3):374-81
   Google Scholar
• Sanchez-Pernaute A, Rubio MÁ, Perez Aguirre E, et al. Single-anastomosis duodenoileal bypass with sleeve gastrectomy: metabolic improvement and weight loss in first 100 patients. Surg Obes Relat Dis 2013;9(5):731-5
   PubMed Web of Science ®Google Scholar
• Rodriguez L, Reyes E, Fagalde P, et al. Pilot clinical study of an endoscopic, removable duodenal-jejunal bypass liner for the treatment of type 2 diabetes. Diabetes Technol Ther 2009;11(11):725-32
   PubMed Web of Science ®Google Scholar
• de Moura EG, Martins BC, Lopes GS, et al. Metabolic improvements in obese type 2 diabetes subjects implanted for 1 year with an endoscopically deployed duodenal-jejunal bypass liner. Diabetes Technol Ther 2012;14(2):183-9
   PubMed Web of Science ®Google Scholar
• de Jonge C, Rensen SS, Verdam FJ, et al. Endoscopic duodenal-jejunal bypass liner rapidly improves type 2 diabetes. Obes Surg 2013;23(9):1354-60
   PubMed Web of Science ®Google Scholar
• Koehestanie P, de Jonge C, Berends FJ, et al. The effect of the endoscopic duodenal-jejunal bypass liner on obesity and type 2 diabetes mellitus, a multicenter randomized controlled trial. Ann Surg 2014;260(6):984-92
   PubMed Web of Science ®Google Scholar
• Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide. 2011. Obes Surg 2013;23:427-36
   PubMed Web of Science ®Google Scholar
• Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and metaanalysis. JAMA 2004;292(14):1724-37
   PubMed Web of Science ®Google Scholar
• Jiménez A, Casamitjana R, Flores L, et al. GLP-1 and the long-term outcome of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery in morbidly obese subjects. Ann Surg 2013;257(5):894-9
   PubMed Web of Science ®Google Scholar
• Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 2012;366:1567-76
   PubMed Web of Science ®Google Scholar
• Yaghoubian A, Tolan A, Stabile BE, et al. Laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy achieve comparable weight loss at 1 year. Am Surg 2012;78(12):1325-8
   PubMed Web of Science ®Google Scholar
• Angrisani L, Lorenzo M, Borrelli V. Laparoscopic adjustable gastric banding versus Roux-en-Y gastric bypass: 5-year results of a prospective randomized trial. Surg Obes Relat Dis 2007;3(2):127-32. discussion 132-3
   PubMed Web of Science ®Google Scholar
• Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009;122:248-56
   PubMed Web of Science ®Google Scholar
• Helmiö M, Victorzon M, Ovaska J, et al. Comparison of short-term outcome of laparoscopic sleeve gastrectomy and gastric bypass in the treatment of morbid obesity: A prospective randomized controlled multicenter SLEEVEPASS study with 6-month follow-up. Scand J Surg 2013;1-7
   Google Scholar
• Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995;222:339-50
   PubMed Web of Science ®Google Scholar
• Sjöström L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004;351:2683-93
   PubMed Web of Science ®Google Scholar
• Tice JA, Karliner L, Walsh J, et al. Gastric banding or bypass? A systematic review comparing the two most popular bariatric procedures. Am J Med 2008;121:885-93
   PubMed Web of Science ®Google Scholar
• Schauer PR, Bhatt DL, Kirwan JP, et al. the STAMPEDE Investigators. Bariatric surgery versus intensive medical therapy for diabetes - 3-Year outcomes. N Engl J Med 2014;370(21):2002-13
   PubMed Web of Science ®Google Scholar
• Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 2012;366(17):1577-85
   PubMed Web of Science ®Google Scholar
• Iaconelli A, Panunzi S, De Gaetano A, et al. Effects of bilio-pancreatic diversion on diabetic complications: a 10-year follow-up. Diabetes Care 2011;34(3):561-7
   PubMed Web of Science ®Google Scholar
• Ikramuddin S, Korner J, Lee WJ, et al. Roux–en–Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: The diabetes surgery study randomized clinical trial. JAMA 2013;309:2240-9
   PubMed Web of Science ®Google Scholar
• Dixon JB, O’Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: A randomized controlled trial. JAMA 2008;299:316-23
   PubMed Web of Science ®Google Scholar
• Chang SH, Stoll CR, Song J, et al. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis. 2003-2012. JAMA Surg 2014;149(3):275-87
   PubMed Web of Science ®Google Scholar
• Buse JB, Caprio S, Cefalu WT, et al. How do we define cure of diabetes? Diabetes Care 2009;32:2133-5
   PubMed Web of Science ®Google Scholar
• Ramos–Levi AM, Sanchez Pernaute A, Cabrerizo L, et al. Remission of type 2 diabetes mellitus should not be the foremost goal after bariatric surgery. Obes Surg 2013;23:2020-5
   PubMed Web of Science ®Google Scholar
• Ramos–Levi A, Sanchez–Pernaute A, Matia P, et al. Diagnosis of diabetes remission after bariatic surgery may be jeopardized by remission criteria and previous hypoglycemic treatment. Obes Surg 2013;23:1520-6
   PubMed Web of Science ®Google Scholar
• Ramos-Levi AM, Cabrerizo L, Matía P, et al. Which criteria should be used to define type 2 diabetes remission after bariatric surgery? BMC Surg 2013;13:8
   PubMedGoogle Scholar
• Pournaras DJ, Aasheim ET, Søvik TT, et al. Effect of the definition of type II diabetes remission in the evaluation of bariatric surgery for metabolic disorders. Br J Surg 2012;99:100-3
   PubMed Web of Science ®Google Scholar
• Miras AD, Risstad H, Baqai N, et al. Application of the International Diabetes Federation and American Diabetes Association criteria in the assessment of metabolic control after bariatric surgery. Diabetes Obes Metab 2014;16:86-9
   PubMed Web of Science ®Google Scholar
• Boza C, Valderas P, Daroch DA, et al. Metabolic surgery: Roux en Y gastric bypass and variables associated with diabetes remission in patients with BMI < 35. Obes Surg 2014;24:1391-7
   PubMed Web of Science ®Google Scholar
• Brethauer SA, Aminian A, Romero TH, et al. Can diabetes be surgically cured? Long term metabolic effects of bariatric surgery in obese patients withtype 2 diabetes mellitus. Ann Surg 2013;258:628-36
   PubMed Web of Science ®Google Scholar
• Ramos-Levi AM, Rubio Herrera MA. Metabolic surgery: Quo Vadis? Endocrinol Nutr 2014;61(1):35-46
   PubMedGoogle Scholar
• Zechmeister-Koss I, Huic M, Fischer S. The duodenal-jejunal bypass liner for the treatment of type 2 diabetes mellitus and/or obesity: a systematic review. Obes Surg 2014;24(2):310-23
   PubMed Web of Science ®Google Scholar
• O’Brien PE, Dixon JB, Laurie C, et al. Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial. Ann Intern Med 2006;144(9):625-33
   PubMed Web of Science ®Google Scholar
• Serrot FJ, Dorman RB, Miller CJ, et al. Comparative effectiveness of bariatric surgery and nonsurgical therapy in adults with type 2 diabetes mellitus and body mass index <35 kg/m2. Surgery 2011;150(4):684-91
   PubMed Web of Science ®Google Scholar
• Lee WJ, Hur KY, Lakadawala M, et al. Gastrointestinal metabolic surgery for the treatment of diabetic patients: a multi-institutional international study. J Gastrointest Surg 2012;16(1):45-51
   PubMed Web of Science ®Google Scholar
• Cohen RV, Pinheiro JC, Schiavon CA, et al. Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity. Diabetes Care 2012;35(7):1420-8
   PubMed Web of Science ®Google Scholar
• Lee WJ, Wang W, Lee YC, et al. Effect of laparoscopic mini-gastric bypass for type 2 diabetes mellitus: comparison of BMI>35 and <35 kg/m2. J Gastrointest Surg 2008;12(5):945-52
   PubMed Web of Science ®Google Scholar
• DePaula AL, Macedo AL, Rassi N, et al. Laparoscopic treatment of metabolic syndrome in patients with type 2 diabetes mellitus. Surg Endosc 2008;22:2670-8
   PubMed Web of Science ®Google Scholar
• Kota SK, Ugale S, Gupta N, et al. Ileal Interposition with Sleeve Gastrectomy for Treatment of type 2 Diabetes. Indian J Endocrinol Metab 2012;16:589-98
   Google Scholar
• Kota SK, Ugale S, Gupta N, Modi KD. Laparoscopic Ileal Interposition with Diverted Sleeve Gastrectomy for treatment of type 2 diabetes. Diab Met Syndr: Clin Res Rev 2012;6:125-31
   PubMedGoogle Scholar
• Astiarraga B, Gastaldelli A, Muscelli E, et al. Biliopancreatic diversion in nonobese patients with type 2 diabetes: impact and mechanisms. J Clin Endocrinol Metab 2013;98(7):2765-73
   PubMed Web of Science ®Google Scholar
• Scopinaro N, Adami GF, Papadia FS, et al. Effects of biliopanceratic diversion on type 2 diabetes in patients with BMI 25 to 35. Ann Surg 2011;253:699-703
   PubMed Web of Science ®Google Scholar
• Fried M, Ribaric G, Buchwald JN, et al. Metabolic surgery for the treatment of type 2 diabetes in patients with BMI <35 kg/m2: an integrative review of early studies. Obes Surg 2010;20:776-90
   PubMed Web of Science ®Google Scholar
• Li Q, Chen L, Yang Z, et al. Metabolic effects of bariatric surgery in type 2 diabetic patients with body mass index < 35 kg/m2. Diabetes Obes Metab 2012;14(3):262-70
   PubMed Web of Science ®Google Scholar
• Reis CE, Alvarez-Leite JI, Bressan J, Alfenas RC. Role of bariatric-metabolic surgery in the treatment of obese type 2 diabetes with body mass index <35 kg/m2: a literature review. Diabetes Technol Ther 2012;14:365-72
   PubMed Web of Science ®Google Scholar
• Maggard-Gibbons M, Maglione M, Livhits M, et al. Bariatric surgery for weight loss and glycemic control in nonmorbidly obese adults with diabetes: a systematic review. JAMA 2013;309(21):2250-61
   PubMed Web of Science ®Google Scholar
• Cummings DE, Overduin J, Foster-Schubert KE. Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution. J Clin Endocrinol Metab 2004;89:2608-15
   PubMed Web of Science ®Google Scholar
• Rubino F, Forgione A, Cummings DE, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg 2006;244:741-9
   PubMed Web of Science ®Google Scholar
• Knop FK. Resolution of type 2 diabetes following gastric bypass surgery. involvement of gut-derived glucagon and glucagonotropic signalling? Diabetologia 2009;52:2270-6
   PubMed Web of Science ®Google Scholar
• Nauck MA, Heimesaat MM, Orskov C, et al. Preserved incretin activity of glucagon-like peptide 1 [7–36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. J Clin Invest 1993;91:301-7
   PubMed Web of Science ®Google Scholar
• Bojsen-Moller KN, Dirksen C, Jorgensen NB, et al. Early enhancements of hepatic and later of peripheral insulin sensitivity combined with increased postprandial insulin secretion contribute to improved glycemic control after Roux-en-Y gastric bypass. Diabetes 2014;63:1725-37
   PubMed Web of Science ®Google Scholar
• Lim EL, Hollingsworth KG, Aribisala BS, et al. Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia 2011;54:2506-14
   PubMed Web of Science ®Google Scholar
• Campos GM, Rabl C, Peeva S, et al. Improvement in peripheral glucose uptake after gastric bypass surgery is observed only after substantial weight loss has occurred and correlates with the magnitude of weight lost. J Gastrointest Surg 2010;14:15-23
   PubMed Web of Science ®Google Scholar
• Madsbad S, Dirksen C, Holst JJ. Mechanisms of changes in glucose metabolism and bodyweight after bariatric surgery. Lancet Diabetes Endocrinol 2014;2:152-64
   PubMed Web of Science ®Google Scholar
• Camastra S, Gastaldelli A, Mari A, et al. Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes. Diabetologia 2011;54(8):2093-102
   PubMed Web of Science ®Google Scholar
• Castagneto M, Mingrone G. The effect of gastrointestinal surgery on insulin resistance and insulin secretion. Curr Atheroscler Rep 2012;14(6):624-30
   PubMed Web of Science ®Google Scholar
• Mari A, Manco M, Guidone C, et al. Restoration of normal glucose tolerance in severely obese patients after bilio-pancreatic diversion: role of insulin sensitivity and beta cell function. Diabetologia 2006;49(9):2136-43
   PubMed Web of Science ®Google Scholar
• Greco AV, Mingrone G, Giancaterini A, et al. Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion. Diabetes 2002;51(1):144-51
   PubMed Web of Science ®Google Scholar
• Rao RS, Yanagisawa R, Kini S. Insulin resistance and bariatric surgery. Obes Rev 2012;13(4):316-28
   PubMed Web of Science ®Google Scholar
• Brethauer SA, Heneghan HM, Eldar S, et al. Early effects of gastric bypass on endothelial function, inflammation, and cardiovascular risk in obese patients. Surg Endosc 2011;25(8):2650-9
   PubMed Web of Science ®Google Scholar
• Toft-Nielsen MB, Damholt MB, Madsbad S, et al. Determinants of the impaired secretion of glucagon-like peptide- 1 in type 2 diabetic patients. J Clin Endocrinol Metab 2001;86:3717-23
   PubMed Web of Science ®Google Scholar
• Vollmer K, Holst JJ, Baller B, et al. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance. Diabetes 2008;57:678-87
   PubMed Web of Science ®Google Scholar
• Lee S, Yabe D, Nohtomi K, et al. Intact glucagon-like peptide-1 levels are not decreased in Japanese patients with type 2 diabetes. Endocr J 2010;7:119-26
   Google Scholar
• Kozawa J, Okita K, Imagawa A, et al. Similar incretin secretion in obese and non-obese Japanese subjects with type 2 diabetes. Biochem Bioph Res Co 2010;393:410-13
   PubMed Web of Science ®Google Scholar
• Nauck AM, Vardarli I, Deacon C F, et al. Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down? Diabetologia 2011;54:10-18
   PubMed Web of Science ®Google Scholar
• Calanna S, Christensen M, Holst JJ, et al. Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies. Diabetologia 2013;56:965-72
   PubMed Web of Science ®Google Scholar
• Singh AK. Glucagon-like peptide 1 and dysglycemia: Conflict in incretin science. Indian J Endocrinol Metab 2015;19(1):182-7
   Google Scholar
• Nauck MA, Wollschläger D, Werner J, et al. Effects of subcutaneous glucagon-like peptide 1 (GLP-1 [7-36 amide]) in patients with NIDDM. Diabetologia 1996;39(12):1546-53
   PubMed Web of Science ®Google Scholar
• Nauck MA, Baranov O, Ritzel RA, Meier JJ. Do current incretin mimetics exploit the full therapeutic potential inherent in GLP-1 receptor stimulation? Diabetologia 2013;56:1878-83
   PubMed Web of Science ®Google Scholar
• Singh AK. Dipeptidyl peptidase-4 inhibitors: Novel mechanism of actions. Indian J Endocrinol Metab 2014;18(6):753-9
   PubMedGoogle Scholar
• Bose M, Olivan B, Teixeira J, et al. Do Incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: What are the evidence? Obes Surg 2009;19:217-29
   PubMed Web of Science ®Google Scholar
• Jorde R, Burhol PG, Johnson JA. The effect of jejunoileal bypass on postprandial release of plasma gastric inhibitory polypeptide (GIP). Scand J Gastroenterol 1981;16:313-19
   PubMed Web of Science ®Google Scholar
• Guidone C, Manco M, Valera-Mora E, et al. Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes 2006;55:2025-31
   PubMed Web of Science ®Google Scholar
• Karra E, Batterham RL. The role of gut hormones in the regulation of bodyweight and energy homeostasis. Mol Cell Endocrinol 2010;25:120-8
   Web of Science ®Google Scholar
• Karra E, Yousseif A, Batterham RL. Mechanisms facilitating weight loss and resolution of type 2 diabetes following bariatric surgery. Trends Endocrinol Metab 2010;21:337-44
   PubMed Web of Science ®Google Scholar
• Naslund E, Kral JG. Impact of gastric bypass surgery on gut hormones and glucose homeostasis in type 2 diabetes. Diabetes 2006;55:S92-7
   Web of Science ®Google Scholar
• Cummings DE, Weigle DS, Frayo RS, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 2002;346:1623-30
   PubMed Web of Science ®Google Scholar
• Zhang W, Zhu DQ, Qiu M. Hypothesis for resolution of diabetes after sleeve gastrectomy. Med Hypotheses 2012;79:278-84
   PubMed Web of Science ®Google Scholar
• Martins L, Fernández-Mallo D, Novelle MG, et al. Hypothalamic mTOR signaling mediates the orexigenic action of ghrelin. PLoS One 2012;7:10
   Google Scholar
• Murphy KG, Bloom SR. Gut hormones and the regulation of energy homeostasis. Nature 2006;444(7121):854-9
   PubMed Web of Science ®Google Scholar
• Drucker DJ. The role of gut hormones in glucose homeostasis. J Clin Invest 2007;117:24-32
   PubMed Web of Science ®Google Scholar
• Mumphrey MB, Patterson LM, Zheng H, Berthoud HR. Roux-en-Y gastric bypass surgery increases number but not density of CCK-, GLP-1-, 5-HT-, and neurotensin expressing enteroendocrine cells in rats. Neurogastroenterol Motil 2013;25:e70-9
   PubMed Web of Science ®Google Scholar
• Jacobsen SH, Olesen SC, Dirksen C, et al. Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in nondiabetic subjects. Obes Surg 2012;22:1084-96
   PubMed Web of Science ®Google Scholar
• Peterli R, Steinert RE, Woelnerhanssen B, et al. Metabolic and hormonal changes after laparoscopic Roux-en-Y Gastric bypass and sleeve gastrectomy: a randomized, prospective trial. Obes Surg 2012;22:740-8
   PubMed Web of Science ®Google Scholar
• Sinclair EM, Drucker DJ. Proglucagon-derived peptides: mechanisms of action and therapeutic potential. Physiology (Bethesda) 2005;20:357-65
   PubMed Web of Science ®Google Scholar
• Suzuki K, Simpson KA, Minnion JS, et al. The role of gut hormones and the hypothalamus in appetite regulation. Endocr J 2010;57:359-72
   PubMed Web of Science ®Google Scholar
• Rubino F, Schauer PR, Kaplan LM, Cummings DE. Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action. Annu Rev Med 2010;61:393-411
   PubMed Web of Science ®Google Scholar
• Papamargaritis D, Miras AD, Le Roux CW. Influence of diabetes surgery on gut hormones and incretins. Nutr Hosp 2013;28(2):95-103
   PubMed Web of Science ®Google Scholar
• Baynes KC, Dhillo WS, Bloom SR. Regulation of food intake by gastrointestinal hormones. Curr Opin Gastroenterol 2006;22:626-31
   PubMed Web of Science ®Google Scholar
• Andreelli F, Amouyal C, Magnan C, Mithieux G. What can bariatric surgery teach us about the pathophysiology of type 2 diabetes? Diabetes Metab 2009;35:499-507
   PubMed Web of Science ®Google Scholar
• Ballantyne GH. Peptide YY: (1–36) and Peptide YY (3–36): Part II. Changes after Gastrointestinal Surgery and Bariatric Surgery: Part I: Distribution, Release and Action appeared in the last issue. Obes Surg 2006;16:795-803
   PubMed Web of Science ®Google Scholar
• Le Roux CW, Welbourn R, Werling M, et al. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg 2007;246:780-5
   PubMed Web of Science ®Google Scholar
• Morinigo R, Moize V, Musri M, et al. Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab 2006;91:1735-40
   PubMed Web of Science ®Google Scholar
• Patti ME, Houten SM, Bianco AC, et al. Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism. Obesity (Silver Spring) 2009;17:1671-7
   PubMed Web of Science ®Google Scholar
• Stefater MA, Sandoval DA, Chambers AP, et al. Sleeve gastrectomy in rats improves postprandial lipid clearance by reducing intestinal triglyceride secretion. Gastroenterology 2011;141:939-49
   PubMed Web of Science ®Google Scholar
• de Aguiar Vallim TQ, Tarling EJ, Edwards PA. Pleiotropic roles of bile acids in metabolism. Cell Metab 2013;17:657-69
   PubMed Web of Science ®Google Scholar
• Ryan KK, Tremaroli V, Clemmensen C, et al. FXR is a molecular target for the effects of vertical sleeve gastrectomy. Nature 2014;509:183-8
   PubMed Web of Science ®Google Scholar
• Tremaroli V, Bäckhed F. Functional interactions between the gut microbiota and host metabolism. Nature 2012;489(7415):242-9
   PubMed Web of Science ®Google Scholar
• Ashrafian H, Athanasiou T, Li JV, et al. Diabetes resolution and hyperinsulinaemia after metabolic Roux-en-Y gastric bypass. Obes Rev 2011;12(5):e257-72
   PubMed Web of Science ®Google Scholar
• Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature 2006;444(7122):1022-3. Comment in: Nature 2006;444(7122):1009-10
   PubMed Web of Science ®Google Scholar
• Liou AP, Paziuk M, Luevano JMJret al. Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci Transl Med 2013;5:178ra41
   PubMed Web of Science ®Google Scholar
• Shin NR, Lee JC, Lee HY, et al. An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut 2014;63:727-35
   PubMed Web of Science ®Google Scholar
• Vrieze A, Van Nood E, Holleman F, et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 2012;143:913-16
   PubMed Web of Science ®Google Scholar
• Madsbad S, Holst JJ. GLP-1 as a mediator in the remission of type 2 diabetes after gastric bypass and sleeve gastrectomy surgery. Diabetes 2014;63:3172-4
   PubMed Web of Science ®Google Scholar
• Wang GF, Yan YX, Xu N, et al. Predictive factors of type 2 diabetes mellitus remission following bariatric surgery: a meta-analysis. Obes Surg 2015;25(2):199-208
   PubMed Web of Science ®Google Scholar
• Kim JW, Cheong JH, Hyung WJ, et al. Outcome after gastrectomy in gastric cancer patients with type 2 diabetes. World J Gastroenterol 2012;18:49-54
   PubMed Web of Science ®Google Scholar
• Still CD, Wood GC, Benotti P, et al. Preoperative prediction of type 2 diabetes remission after Roux-en-Y gastric bypass surgery: a retrospective cohort study. Lancet Diabetes Endocrinol 2014;2:38-45
   PubMed Web of Science ®Google Scholar
• Ugale S, Gupta N, Modi KD, et al. Prediction of remission after metabolic surgery using a novel scoring system in type 2 diabetes – a retrospective cohort study. J Diabetes Metab Disord 2014;13:89
   Google Scholar
• Marsk R, Jonas E, Rasmussen F, Naslund E. Nationwide cohort study of post-gastric bypass hypoglycaemia including 5040 patients undergoing surgery for obesity in. 1986–2006 in Sweden. Diabetologia 2010;53:2307-11
   PubMed Web of Science ®Google Scholar
• Flum DR, Belle SH, King WC, et al. Longitudinal Assessment of Bariatric Surgery (LABS) Consortium. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med 2009;361:445-54
   PubMed Web of Science ®Google Scholar
• Bult MJ, van Dalen T, Muller AF. Surgical treatment of obesity. Eur J Endocrinol 2008;158:135-45
   PubMed Web of Science ®Google Scholar
• Bal BS, Finelli FC, Shope TR, Koch TR. Nutritional deficiencies after bariatric surgery. Nat Rev Endocrinol 2012;8:544-56
   PubMed Web of Science ®Google Scholar
• Keogh JB, Turner KM, McDonald F, et al. Remis-sion of diabetes in patients with long-standing type 2 diabetes following placement of adjustable gastric band: a retrospectivecase control study. Diabetes Obes Metab 2013;15:383-5
   PubMed Web of Science ®Google Scholar
• Arterburn DE, Bogart A, Sherwood NE, et al. A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass. Obes Surg 2013;23:93-102
   PubMed Web of Science ®Google Scholar
• Kadera BE, Lum K, Grant J, et al. Remission of type 2 diabetes after Roux-en-Y gastric bypass is associated with greater weight loss. Surg Obes Relat Dis 2009;5:305-9
   PubMed Web of Science ®Google Scholar
• DiGiorgi M, Rosen DJ, Choi JJ, et al. Re-emergence of diabetes after gastric bypass in patients with mid to long term follow-up. Surg Obes Relat Dis 2010;6:249-53
   PubMed Web of Science ®Google Scholar
• Chikunguwo SM, Wolfe LG, Dodson P, et al. Analysis of factor associated with durable remission of diabetes after Roux-en Y gastric bypass. Surg Obes Relat Dis 2010;6:254-9
   PubMed Web of Science ®Google Scholar
• Kashyap SR, Schauer P. Clinical considerations for the management of residual diabetes following bariatric surgery. Diabetes Obes Metab 2012;14:733-9
   Web of Science ®Google Scholar